Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > CFO just exercised

<< Previous

Bullboard Posts

Next >>

Comment by lscfaon Jan 24, 2022 3:50pm

185 Views

Post# 34354857

RE:RE:RE:CFO just exercised

$ 1 million cash raised since jul 31 qtr end + revenue from R+F....

Effective Date	Expiry Date	Issued	Change		Proceeds
18/Jan/2022		236,000,000	-67,566	$0.16	-$10,811
01/Nov/2021	17/Jan/2022	236,067,566	3,022,500	$0.16	$483,600
26/Oct/2021	31/Oct/2021	233,045,066	2,418,600	$0.18	$435,348
06/Oct/2021	25/Oct/2021	230,626,466	300,000	$0.18	$54,000
29/Jul/2021	05/Oct/2021	230,326,466	252,500	$0.18	$45,450
30/Jun/2021	28/Jul/2021	230,073,966		Total	$1,007,587